{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:17:26Z","timestamp":1790936246848,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-84","type":"journal-article","created":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T12:14:52Z","timestamp":1365768892000},"source":"Crossref","is-referenced-by-count":16,"title":["Treatment of patients with metastatic renal cell carcinoma undergoing hemodialysis: case report of two patients and short literature review"],"prefix":"10.1186","volume":"14","author":[{"given":"John","family":"Syrios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Kechagias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tsavaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"issue":"3","key":"514_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00345-010-0519-5","volume":"28","author":"E Herrmann","year":"2010","unstructured":"Herrmann E, Bierer S, Wulfing C: Update on systemic therapies of metastatic renal cell carcinoma. World J Urol. 2010, 28 (3): 303-309. 10.1007\/s00345-010-0519-5.","journal-title":"World J Urol"},{"issue":"1","key":"514_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.eururo.2005.03.004","volume":"48","author":"HS Hofmann","year":"2005","unstructured":"Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE: Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005, 48 (1): 77-81. 10.1016\/j.eururo.2005.03.004. discussion 81\u201372","journal-title":"Eur Urol"},{"issue":"2","key":"514_CR3","first-page":"3954","volume":"15","author":"U Athar","year":"2008","unstructured":"Athar U, Gentile TC: Treatment options for metastatic renal cell carcinoma: a review. Can J Urol. 2008, 15 (2): 3954-3966.","journal-title":"Can J Urol"},{"issue":"12","key":"514_CR4","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","volume":"23","author":"JJ Patard","year":"2005","unstructured":"Patard JJ, Leray E, Rioux-Leclercq N, Cindolo L, Ficarra V, Zisman A, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Guille F, Chopin DK, Mulders PF, Wood CG, Swanson DA, Figlin RA, Belldegrun AS, Pantuck AJ: Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005, 23 (12): 2763-2771.","journal-title":"J Clin Oncol"},{"issue":"24","key":"514_CR5","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","volume":"22","author":"WY Kim","year":"2004","unstructured":"Kim WY, Kaelin WG: Role of VHL gene mutation in human cancer. J Clin Oncol. 2004, 22 (24): 4991-5004. 10.1200\/JCO.2004.05.061.","journal-title":"J Clin Oncol"},{"issue":"2","key":"514_CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0094-0143(21)00481-X","volume":"20","author":"JR Gnarra","year":"1993","unstructured":"Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM: Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am. 1993, 20 (2): 207-216.","journal-title":"Urol Clin North Am"},{"issue":"23","key":"514_CR7","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2008.20.6524","volume":"27","author":"F Wiklund","year":"2009","unstructured":"Wiklund F, Tretli S, Choueiri TK, Signoretti S, Fall K, Adami HO: Risk of bilateral renal cell cancer. J Clin Oncol. 2009, 27 (23): 3737-3741. 10.1200\/JCO.2008.20.6524.","journal-title":"J Clin Oncol"},{"issue":"23","key":"514_CR8","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMoa003013","volume":"345","author":"RC Flanigan","year":"2001","unstructured":"Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, Caton JR, Munshi N, Crawford ED: Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001, 345 (23): 1655-1659. 10.1056\/NEJMoa003013.","journal-title":"N Engl J Med"},{"issue":"4","key":"514_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.ucl.2008.07.008","volume":"35","author":"P Russo","year":"2008","unstructured":"Russo P, Huang W: The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am. 2008, 35 (4): 635-643. 10.1016\/j.ucl.2008.07.008. vii","journal-title":"Urol Clin North Am"},{"issue":"8","key":"514_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bjc.2012.327","volume":"107","author":"G Procopio","year":"2012","unstructured":"Procopio G, Verzoni E, Iacovelli R, Biasoni D, Testa I, Porcu L, De Braud F: Prognostic factors for survival in patients with metastatic renal cell carcinoma treated with targeted therapies. Br J Cancer. 2012, 107 (8): 1227-1232. 10.1038\/bjc.2012.327.","journal-title":"Br J Cancer"},{"issue":"7","key":"514_CR11","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","volume":"21","author":"N Janus","year":"2010","unstructured":"Janus N, Thariat J, Boulanger H, Deray G, Launay-Vacher V: Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol. 2010, 21 (7): 1395-1403. 10.1093\/annonc\/mdp598.","journal-title":"Ann Oncol"},{"issue":"6","key":"514_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","volume":"110","author":"V Launay-Vacher","year":"2007","unstructured":"Launay-Vacher V, Oudard S, Janus N, Gligorov J, Pourrat X, Rixe O, Morere JF, Beuzeboc P, Deray G: Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study. Cancer. 2007, 110 (6): 1376-1384. 10.1002\/cncr.22904.","journal-title":"Cancer"},{"issue":"1","key":"514_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/annonc\/mdn626","volume":"20","author":"H Izzedine","year":"2009","unstructured":"Izzedine H, Etienne-Grimaldi MC, Renee N, Vignot S, Milano G: Pharmacokinetics of sunitinib in hemodialysis. Ann Oncol. 2009, 20 (1): 190-192.","journal-title":"Ann Oncol"},{"issue":"34","key":"514_CR14","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1200\/JCO.2008.19.3144","volume":"26","author":"G Lunardi","year":"2008","unstructured":"Lunardi G, Vannozzi MO, Armirotti A, Nicodemo M, Venturini M, Cavallini L: Temsirolimus in patients with renal cancer on hemodialysis. J Clin Oncol. 2008, 26 (34): 5652-5653. 10.1200\/JCO.2008.19.3144. author reply 5653\u20135654","journal-title":"J Clin Oncol"},{"issue":"11","key":"514_CR15","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1200\/JCO.2008.20.0931","volume":"27","author":"AA Miller","year":"2009","unstructured":"Miller AA, Murry DJ, Owzar K, Hollis DR, Kennedy EB, Abou-Alfa G, Desai A, Hwang J, Villalona-Calero MA, Dees EC, Lewis LD, Fakih MG, Edelman MJ, Millard F, Frank RC, Hohl RJ, Ratain MJ: Phase I and pharmacokinetic study of sorafenib in patients with hepatic or renal dysfunction: CALGB 60301. J Clin Oncol. 2009, 27 (11): 1800-1805. 10.1200\/JCO.2008.20.0931.","journal-title":"J Clin Oncol"},{"issue":"11","key":"514_CR16","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1093\/annonc\/mds477","volume":"23","author":"A Thiery-Vuillemin","year":"2012","unstructured":"Thiery-Vuillemin A, Curtit E, Maurina T, Montange D, Succi C, Nguyen T, Kim S, Montcuquet P, Pivot X, Royer B: Hemodialysis does not affect everolimus pharmacokinetics: two cases of patients with metastatic renal cell cancer. Ann Oncol. 2012, 23 (11): 2992-2993. 10.1093\/annonc\/mds477.","journal-title":"Ann Oncol"},{"issue":"3","key":"514_CR17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000474757","volume":"22","author":"C Henriksson","year":"1992","unstructured":"Henriksson C, Geterud K, Aldenborg F, Zachrisson BF, Pettersson S: Bilateral asynchronous renal cell carcinoma. Computed tomography of the contralateral kidney 10\u201343\u00a0years after nephrectomy. Eur Urol. 1992, 22 (3): 209-212.","journal-title":"Eur Urol"},{"issue":"9","key":"514_CR18","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.2002.08.099","volume":"20","author":"F Rabbani","year":"2002","unstructured":"Rabbani F, Herr HW, Almahmeed T, Russo P: Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J Clin Oncol. 2002, 20 (9): 2370-2375. 10.1200\/JCO.2002.08.099.","journal-title":"J Clin Oncol"},{"issue":"6","key":"514_CR19","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.juro.2007.01.122","volume":"177","author":"T Klatte","year":"2007","unstructured":"Klatte T, Patard JJ, Wunderlich H, Goel RH, Lam JS, Junker K, Schubert J, Bohm M, Allhoff EP, Kabbinavar FF, Crepel M, Cindolo L, De La Taille A, Tostain J, Mejean A, Soulie M, Bellec L, Bernhard JC, Ferriere JM, Pfister C, Albouy B, Colombel M, Zisman A, Belldegrun AS, Pantuck AJ: Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol. 2007, 177 (6): 2081-2086. 10.1016\/j.juro.2007.01.122. discussion 2086\u20132087","journal-title":"J Urol"},{"issue":"4","key":"514_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2011.06.049","volume":"60","author":"B Ljungberg","year":"2011","unstructured":"Ljungberg B, Campbell SC, Choi HY, Jacqmin D, Lee JE, Weikert S, Kiemeney LA: The epidemiology of renal cell carcinoma. Eur Urol. 2011, 60 (4): 615-621. 10.1016\/j.eururo.2011.06.049.","journal-title":"Eur Urol"},{"issue":"6","key":"514_CR21","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1016\/S0022-5347(05)68071-8","volume":"162","author":"KS Hafez","year":"1999","unstructured":"Hafez KS, Fergany AF, Novick AC: Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999, 162 (6): 1930-1933. 10.1016\/S0022-5347(05)68071-8.","journal-title":"J Urol"},{"issue":"2","key":"514_CR22","first-page":"66","volume":"26","author":"T Lobbedez","year":"1997","unstructured":"Lobbedez T, Hurault de Ligny B, Galateau F, Potier J, Elie H, Ryckelynck JP: Synchronous bilateral renal cell carcinoma. Renal transplantation after nephrectomy. Presse Med. 1997, 26 (2): 66-69.","journal-title":"Presse Med"},{"key":"514_CR23","volume-title":"Dialysis in Clinical Pharmacokinetics. Concepts and Applications","year":"1995","unstructured":"Dialysis in Clinical Pharmacokinetics. Concepts and Applications. Edited by: Rowland M, Tozer T. 1995, Philadelphia: Lippincott Williams & Wilkins, 3","edition":"3"},{"issue":"Suppl 1","key":"514_CR24","doi-asserted-by":"publisher","first-page":"i13","DOI":"10.1093\/annonc\/mdp074","volume":"20","author":"J Bellmunt","year":"2009","unstructured":"Bellmunt J: Future developments in renal cell carcinoma. Ann Oncol. 2009, 20 (Suppl 1): i13-i17.","journal-title":"Ann Oncol"},{"issue":"2","key":"514_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.urolonc.2009.03.033","volume":"28","author":"M Staehler","year":"2010","unstructured":"Staehler M, Haseke N, Zilinberg E, Stadler T, Karl A, Siebels M, Durr HR, Siegert S, Jauch KW, Bruns CJ, Stief CG: Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Urol Oncol. 2010, 28 (2): 139-144. 10.1016\/j.urolonc.2009.03.033.","journal-title":"Urol Oncol"},{"issue":"2","key":"514_CR26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1542-4758.2011.00540.x","volume":"15","author":"K Nemoto","year":"2011","unstructured":"Nemoto K, Miura T, Shioji G, Tsuboi N: Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy. Hemodial Int. 2011, 15 (2): 288-292. 10.1111\/j.1542-4758.2011.00540.x.","journal-title":"Hemodial Int"},{"issue":"5","key":"514_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1046\/j.1442-2042.2000.00158.x","volume":"7","author":"K Hanazawa","year":"2000","unstructured":"Hanazawa K, Tanaka M, Watanabe R, Fujime M: Interferon therapy for renal cell carcinoma in hemodialysis patients: report of two patients. Int J Urol. 2000, 7 (5): 189-192. 10.1046\/j.1442-2042.2000.00158.x.","journal-title":"Int J Urol"},{"issue":"3","key":"514_CR28","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/ndt\/gfl664","volume":"22","author":"N Garnier-Viougeat","year":"2007","unstructured":"Garnier-Viougeat N, Rixe O, Paintaud G, Ternant D, Degenne D, Mouawad R, Deray G, Izzedine H: Pharmacokinetics of bevacizumab in haemodialysis. Nephrol Dial Transplant. 2007, 22 (3): 975-","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"514_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00280-011-1633-9","volume":"68","author":"T Horimatsu","year":"2011","unstructured":"Horimatsu T, Miyamoto S, Morita S, Mashimo Y, Ezoe Y, Muto M, Chiba T: Pharmacokinetics of oxaliplatin in a hemodialytic patient treated with modified FOLFOX-6 plus bevacizumab therapy. Cancer Chemother Pharmacol. 2011, 68 (1): 263-266. 10.1007\/s00280-011-1633-9.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"514_CR30","first-page":"2250","volume":"38","author":"H Kuwabara","year":"2011","unstructured":"Kuwabara H, Baba H, Wakabayashi M, Nakamura H, Sanada T, Baba H, Nakajima K, Goseki N: mFOLFOX6 and FOLFIRI\/bevacizumab treatment in a patient on hemodialysis with metastatic colon cancer. Gan To Kagaku Ryoho. 2011, 38 (12): 2250-2252.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"8","key":"514_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/j.1464-410X.2010.09990.x","volume":"108","author":"D Josephs","year":"2011","unstructured":"Josephs D, Hutson TE, Cowey CL, Pickering LM, Larkin JM, Gore ME, Van Hemelrijck M, McDermott DF, Powles T, Chowdhury P, Karapetis C, Harper PG, Choueiri TK, Chowdhury S: Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis. BJU Int. 2011, 108 (8): 1279-1283. 10.1111\/j.1464-410X.2010.09990.x.","journal-title":"BJU Int"},{"issue":"5","key":"514_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1464-410X.2012.10946.x","volume":"110","author":"C Masini","year":"2012","unstructured":"Masini C, Sabbatini R, Porta C, Procopio G, Di Lorenzo G, Onofri A, Buti S, Iacovelli R, Invernizzi R, Moscetti L, Aste MG, Pagano M, Grosso F, Lucia Manenti A, Ortega C, Cosmai L, Del Giovane C, Conte PF: Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey. BJU Int. 2012, 110 (5): 692-698. 10.1111\/j.1464-410X.2012.10946.x.","journal-title":"BJU Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-84\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-84","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-84.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,13]],"date-time":"2022-02-13T17:05:36Z","timestamp":1644771936000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["514"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-84","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]},"article-number":"84"}}